Preparing a Balance Sheet The following financial information is known about Pfizer, Inc. for the year ended December 31, 2015. (all amounts in millions): a. The balance of cash and cash equivalents was $3,740. b. Short-term investments have a fair market value of $19,649. c. Gross accounts receivable total $8,758, which includes $384 that is not expected to be collected. d. Inventory has a cost basis of $7,711. e. Current tax assets total $2,662; other current assets total $2,163, and long-term investments total $16,197. f. Property, plant and equipment have a cost basis of $27,466 and accumulated depreciation of $13,502. g. Intangible assets have a cost basis of $89,396 and accumulated amortization of $49,040. h. Noncurrent deferred tax assets, other taxes assets, and other noncurrent assets total $5,293 and Goodwill totals $48,242. i. Accounts payable total $3,719 accrued expenses payable total $15,619; and, short-term borrowings total $10,160. j. Long-term debt totals $29,016, pension and post-retirement benefit obligations total $8,119. k. Noncurrent deferred tax liabilities $27,075, and other taxes payable and noncurrent liabilities of $9,249. I. Shareholders' equity totals $65,116, composed of retained earnings of $72,191, other comprehensive income (loss) of $(9,522), treasury stock of negative $79,252, and contributed capital of $81,699. Equity attributable to noncontrolling interests totals $278.